Pharmaceutical Business review

Applied DNA Sciences and Smiths Detection sign MoU

Under the terms of the agreement, Smiths will provide Applied DNA Sciences (APDN) with exclusive use of the Bio-seeqPLUS platform, centered upon a portable, DNA-verifying device for authentication, anti-counterfeiting and anti-diversion. When used in combination with APDN’s SigNature DNA markers, the Bio-seeq PLUS will provide rapid forensic authentication in the field.

James Hayward, APDN president and CEO stated: “The Bio-seeqPLUS rounds out our three-pronged offering for authenticating originality – nearly instantaneous optical screening, backed up by in-field forensic marker verification, and ultimately supported when required for legal reasons, by in-lab DNA sequencing.”